Latent Health vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $80M Series A (Mar 2026) co-led by Spark Capital and Transformation Capital. 2M+ patients/year. Partners with 50% of top 20 US health systems. McKesson Ventures strategic investor.
About
Latent Health is a medication access and prior authorization automation platform that uses its Clinical Reasoning Engine to ingest EHR data, interpret drug approval criteria, and automate the full medication access workflow end-to-end. The company raised $80 million in Series A financing in March 2026 co-led by Spark Capital and Transformation Capital, with McKesson Ventures, General Catalyst, and Y Combinator as co-investors. The platform serves 2 million+ patients annually and is partnered with 50% of the top 20 US health systems.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.